Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc

Bullboard Posts

Comment by StockMagicianon May 29, 2017 11:48am

189 Views

Post# 26295968

RE:Fabrice Taylor

Yeah but CHH isn't the one being 'worked' today. It is this stock, so place your bets and lets see which one he pumps 26 hours from now.

digitel wrote: Maybe someone will ask Fabrice is he really has been told CZO can extract THC "better than anyone", where he heard it, and when we might hear about this from CZO?

retiredcf

image: https://www.stockhouse.com/Stockhouse/images/stars-mask.png

User Actions

16 minutes ago 10 Reads
Post# 26293493

Rate this post

image: https://www.stockhouse.com/Stockhouse/images/stars-mask.png

v

Fabrice Taylor

As a reminder, he's scheduled to be back on Market Call this Tuesday. As can be seen, last time he was on, he made CHH a top pick. If he liked it then, one could assume that he would like it even more now given that it's 11% cheaper than when he made the recommendation. GLTA

2017-02-16 TOP PICK Fabrice Taylor

One division does private surgeries that are not covered by healthcare. Every year they cut more and more services from provincial plans so there are more and more opportunities to use their services. The other division is an industrial pharmacy that services businesses like seniors homes. It is a turnaround story. They used to have a lot of debt, but margins have improved. He is impressed with management. The stock has positive tailwinds and it is a turnaround story. (Analysts’ target: $1.02).

Login to show your approval Login to show your disapproval / Be the first to comment

Price:

$0.790

Subject:

NORTH AMERICAN

Bias:

SELECTIVE

Owned:

Yes

Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.chh&postid=26293493#E1kAHC6EPShUJs4W.99